Nextcure to present at the h.c. wainwright 5th annual neuro perspectives virtual conference

Beltsville, md., june 20, 2024 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies, today announced that it will present and host institutional investor meetings at the h.c. wainwright 5th annual neuro perspectives virtual conference on thursday, june 27, 2024.
NXTC Ratings Summary
NXTC Quant Ranking